Briton RylePosted December 19, 2016
Here's a question for you: Which companies are the most powerful in the world today? Wealth Daily editor Briton Ryle discusses what makes a company "powerful"...
Jason StutmanPosted December 18, 2016
Jason Stutman explains why the vehicle-to-vehicle (V2V) technology market is poised to explode.
Jason WilliamsPosted December 16, 2016
When it comes to New Year's resolutions, most people end up letting their goals fall by the wayside after a short time. That's why you should forget resolutions this year and make life changes...
Alex KoyfmanPosted December 15, 2016
Ever since Trump's electoral victory five weeks ago, I've been hearing one phrase more and more often: "Dow 20,000." But is this really a sign that things are good and bound to get better?
Monica SavagliaPosted December 14, 2016
Blue Apron, one of the most popular meal-kit companies on the market, could be leaning towards a 2017 IPO.
Briton RylePosted December 14, 2016
Wealth Daily editor Brit Ryle continues his 2017 predictions with his eight calls for the year ahead.
Jeff SiegelPosted December 13, 2016
Last week, we gave Wealth Daily readers the chance to partake in a private deal. Emblem Cannabis (TSX-V: EMC) soars in its debut, making early investors a fortune!
Briton RylePosted December 12, 2016
You know the drill: First I review my 2016 predictions. Then in my next article I will unleash Predictions 2017 on the world.
Jason StutmanPosted December 10, 2016
Harsh as it may sound, Jack Dorsey’s only success with Twitter and Square has been duping public investors out of their money.
Alex KoyfmanPosted December 8, 2016
Earlier this week, President-elect Trump announced that he was planning to "cancel" Boeing's (NYSE: BA) standing contract to supply the next Air Force One fleet. Should we take this threat seriously?
Briton RylePosted December 7, 2016
I can't tell you that our next president will actually be more business friendly. But the 180-degree shift in market sentiment says investors believe he will be.
Jeff SiegelPosted December 6, 2016
Big Pharma is finally embracing cannabis. Wealth Daily Editor Jeff Siegel explains how you can get a piece of the action with this pre-IPO deal.